Karin Leiderman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Karin Leiderman has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
Suzanne S. Sindi
Department of Applied Mathematics, University of California Merced, Merced, California, USA
7 shared publicationsAaron L. Fogelson
Affiliation Departments of Mathematics and Biomedical Engineering, University of Utah, Salt Lake City, Utah, United States of America
6 shared publicationsDougald M. Monroe
Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
5 shared publicationsMichael T. Stobb
Department of Mathematics, Coe College, Cedar Rapids, Iowa, USA
4 shared publications- Suzanne S. Sindi
Department of Applied Mathematics, University of California, Merced, Merced, USA
4 shared publications - Aaron L. Fogelson
University of Utah
3 shared publications
Latest Publications
- 16 October 2026
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 289
Sensitivity of ECG QRS complexes to His–Purkinje structure in whole-heart electrophysiology models
- 16 October 2026
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 289
Sensitivity of ECG QRS complexes to His–Purkinje structure in whole-heart electrophysiology models
- Open Access
- 27 August 2026
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 24 (11) , 3884-3894
Mathematical modeling of flow-mediated thrombin generation after treatment of postoperative bleeding in cardiac surgery with cardiopulmonary bypass
- 27 August 2026
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 24 (11) , 3884-3894
Open AccessMathematical modeling of flow-mediated thrombin generation after treatment of postoperative bleeding in cardiac surgery with cardiopulmonary bypass
- 24 July 2026
- Published by American Society of Hematology in Blood
Factor V is an anticoagulant of the extrinsic pathway of coagulation and modifier of thrombin generation in hemophilia A
Factor V (FV) links procoagulant amplification to anticoagulant feedback, but how FV limits tissue factor-initiated coagulation are not fully defined. We hypothesized that procofactor FV downregulates factor X (FX) activation by tissue factor:factor VIIa (TF:FVIIa), independently of tissue factor pathway inhibitor α (TFPIα), and that this mechanism is especially important in hemophilia. Thrombin generation was measured in FV/FVIII‑immunodepleted plasma and synthetic plasma while titrating FV, with TFPIα removed, blocked, or re-added. TF:FVIIa activation of FX was measured on phosphatidylserine‑containing or phosphatidylserine‑free liposomes with antibodies against the FV light chain and C2 domain. FV and TFPIα levels modulated thrombin generation in plasma from people with hemophilia A. In TF‑initiated coagulation lacking TFPIα, thrombin generation peaked at 2 nM FV and decreased as FV increased; at 20 nM FV (normal concentration), peak thrombin and thrombin generation rate were reduced by up to 50-80%, with larger effects at low FVIII. In purified TF:FVIIa assays, FV reduced FX activation by ~80% at physiologic concentration and inhibited FX activation on TF-expressing fibroblasts. Increasing PS content enhanced FX activation and increased the FV-sensitive component, while blocking the FV light chain or C2 domain partially relieved inhibition. In hemophilia A plasma, higher FV was associated with longer lag time and time-to-peak, and lower peak thrombin independent of TFPIα. Thus, FV is an endogenous anticoagulant that inhibits TF-initiated coagulation by limiting FX activation by TF:FVIIa through a membrane-dependent mechanism. This mechanism refines models of coagulation initiation and may help explain how FV variation contributes to bleeding and thrombosis.
- 24 July 2026
- Published by American Society of Hematology in Blood
Factor V is an anticoagulant of the extrinsic pathway of coagulation and modifier of thrombin generation in hemophilia A
Factor V (FV) links procoagulant amplification to anticoagulant feedback, but how FV limits tissue factor-initiated coagulation are not fully defined. We hypothesized that procofactor FV downregulates factor X (FX) activation by tissue factor:factor VIIa (TF:FVIIa), independently of tissue factor pathway inhibitor α (TFPIα), and that this mechanism is especially important in hemophilia. Thrombin generation was measured in FV/FVIII‑immunodepleted plasma and synthetic plasma while titrating FV, with TFPIα removed, blocked, or re-added. TF:FVIIa activation of FX was measured on phosphatidylserine‑containing or phosphatidylserine‑free liposomes with antibodies against the FV light chain and C2 domain. FV and TFPIα levels modulated thrombin generation in plasma from people with hemophilia A. In TF‑initiated coagulation lacking TFPIα, thrombin generation peaked at 2 nM FV and decreased as FV increased; at 20 nM FV (normal concentration), peak thrombin and thrombin generation rate were reduced by up to 50-80%, with larger effects at low FVIII. In purified TF:FVIIa assays, FV reduced FX activation by ~80% at physiologic concentration and inhibited FX activation on TF-expressing fibroblasts. Increasing PS content enhanced FX activation and increased the FV-sensitive component, while blocking the FV light chain or C2 domain partially relieved inhibition. In hemophilia A plasma, higher FV was associated with longer lag time and time-to-peak, and lower peak thrombin independent of TFPIα. Thus, FV is an endogenous anticoagulant that inhibits TF-initiated coagulation by limiting FX activation by TF:FVIIa through a membrane-dependent mechanism. This mechanism refines models of coagulation initiation and may help explain how FV variation contributes to bleeding and thrombosis.
- Open Access
- 18 May 2026
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 22 (5) , e1014241
A three-dimensional shear dependent continuum model of platelet aggregation under flow
Platelet aggregation under flow is a key component of hemostasis, strongly influenced by shear-dependent interactions mediated by von Willebrand factor (vWF). We present a three-dimensional continuum model that incorporates shear-dependent platelet adhesion, cohesion, and activation. The model tracks seven platelet species and integrates shear-dependent kinetics for vWF-mediated binding and activation. Parameterization was guided by microfluidic experiments under controlled shear rates (300/s and 1500/s) with platelet activation pathways inhibited. Simulations reproduce experimental aggregate growth and occlusion dynamics in both straight channels and physiologically relevant extravascular geometries, where shear rates exceed 8000/s. Functional forms for shear-dependent on- and off-rates were implemented using piecewise and nonlinear scaling: on-rates exhibit double-threshold behavior with saturation at high shear, while off-rates combine linear and exponential terms to capture bond lifetime changes under extreme shear. Simulations using these rate forms reproduced occlusion times within the experimentally observed range. Qualitative comparisons with microfluidic imaging further demonstrated that the model reproduces intrathrombus heterogeneity, including the core–shell architecture with activated platelets concentrated near the collagen surface and unactivated platelets forming an outer shell. These results provide mechanistic insight into how shear-dependent vWF-mediated interactions regulate thrombus growth and occlusion. By linking microfluidic data with continuum-scale modeling, this framework provides a computationally efficient platform to study shear-regulated platelet aggregation and its contribution to hemostatic occlusion under physiologic and pathologic flow conditions.
- 18 May 2026
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 22 (5) , e1014241
Open AccessA three-dimensional shear dependent continuum model of platelet aggregation under flow
Platelet aggregation under flow is a key component of hemostasis, strongly influenced by shear-dependent interactions mediated by von Willebrand factor (vWF). We present a three-dimensional continuum model that incorporates shear-dependent platelet adhesion, cohesion, and activation. The model tracks seven platelet species and integrates shear-dependent kinetics for vWF-mediated binding and activation. Parameterization was guided by microfluidic experiments under controlled shear rates (300/s and 1500/s) with platelet activation pathways inhibited. Simulations reproduce experimental aggregate growth and occlusion dynamics in both straight channels and physiologically relevant extravascular geometries, where shear rates exceed 8000/s. Functional forms for shear-dependent on- and off-rates were implemented using piecewise and nonlinear scaling: on-rates exhibit double-threshold behavior with saturation at high shear, while off-rates combine linear and exponential terms to capture bond lifetime changes under extreme shear. Simulations using these rate forms reproduced occlusion times within the experimentally observed range. Qualitative comparisons with microfluidic imaging further demonstrated that the model reproduces intrathrombus heterogeneity, including the core–shell architecture with activated platelets concentrated near the collagen surface and unactivated platelets forming an outer shell. These results provide mechanistic insight into how shear-dependent vWF-mediated interactions regulate thrombus growth and occlusion. By linking microfluidic data with continuum-scale modeling, this framework provides a computationally efficient platform to study shear-regulated platelet aggregation and its contribution to hemostatic occlusion under physiologic and pathologic flow conditions.
- Open Access
- 10 March 2026
- Published by Elsevier in Biophysical Journal
- Vol. 125 (7) , 1840-1855
Continuum and discrete modeling of binding-site distribution-mediated reactions on lipid surfaces
- 10 March 2026
- Published by Elsevier in Biophysical Journal
- Vol. 125 (7) , 1840-1855
Open AccessContinuum and discrete modeling of binding-site distribution-mediated reactions on lipid surfaces
- Open Access
- 16 July 2025
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 23 (10) , 3111-3123
Mathematical analysis of emicizumab: affinity-driven complex formation and lipid-surface reactions
- 16 July 2025
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 23 (10) , 3111-3123
Open AccessMathematical analysis of emicizumab: affinity-driven complex formation and lipid-surface reactions
- Open Access
- 15 November 2024
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 20 (11) , e1012509
A new look at TFPI inhibition of factor X activation
Blood coagulation is a vital physiological process involving a complex network of biochemical reactions, which converge to form a blood clot that repairs vascular injury. This process unfolds in three phases: initiation, amplification, and propagation, ultimately leading to thrombin formation. Coagulation begins when tissue factor (TF) is exposed on an injured vessel’s wall. The first step is when activated factor VII (VIIa) in the plasma binds to TF, forming complex TF:VIIa, which activates factor X. Activated factor X (Xa) is necessary for coagulation, so the regulation of its activation is crucial. Tissue Factor Pathway Inhibitor (TFPI) is a critical regulator of the initiation phase as it inhibits the activation of factor X. While previous studies have proposed two pathways—direct and indirect binding—for TFPI’s inhibitory role, the specific biochemical reactions and their rates remain ambiguous. Many existing mathematical models only assume an indirect pathway, which may be less effective under physiological flow conditions. In this study, we revisit datasets from two experiments focused on activated factor X formation in the presence of TFPI. We employ an adaptive Metropolis method for parameter estimation to reinvestigate a previously proposed biochemical scheme and corresponding rates for both inhibition pathways. Our findings show that both pathways are essential to replicate the static experimental results. Previous studies have suggested that flow itself makes a significant contribution to the inhibition of factor X activation. We added flow to this model with our estimated parameters to determine the contribution of the two inhibition pathways under these conditions. We found that direct binding of TFPI is necessary for inhibition under flow. The indirect pathway has a weaker inhibitory effect due to removal of solution phase inhibitory complexes by flow.
- 15 November 2024
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 20 (11) , e1012509
Open AccessA new look at TFPI inhibition of factor X activation
Blood coagulation is a vital physiological process involving a complex network of biochemical reactions, which converge to form a blood clot that repairs vascular injury. This process unfolds in three phases: initiation, amplification, and propagation, ultimately leading to thrombin formation. Coagulation begins when tissue factor (TF) is exposed on an injured vessel’s wall. The first step is when activated factor VII (VIIa) in the plasma binds to TF, forming complex TF:VIIa, which activates factor X. Activated factor X (Xa) is necessary for coagulation, so the regulation of its activation is crucial. Tissue Factor Pathway Inhibitor (TFPI) is a critical regulator of the initiation phase as it inhibits the activation of factor X. While previous studies have proposed two pathways—direct and indirect binding—for TFPI’s inhibitory role, the specific biochemical reactions and their rates remain ambiguous. Many existing mathematical models only assume an indirect pathway, which may be less effective under physiological flow conditions. In this study, we revisit datasets from two experiments focused on activated factor X formation in the presence of TFPI. We employ an adaptive Metropolis method for parameter estimation to reinvestigate a previously proposed biochemical scheme and corresponding rates for both inhibition pathways. Our findings show that both pathways are essential to replicate the static experimental results. Previous studies have suggested that flow itself makes a significant contribution to the inhibition of factor X activation. We added flow to this model with our estimated parameters to determine the contribution of the two inhibition pathways under these conditions. We found that direct binding of TFPI is necessary for inhibition under flow. The indirect pathway has a weaker inhibitory effect due to removal of solution phase inhibitory complexes by flow.
- Open Access
- 12 November 2024
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 23 (2) , 480-491
Examining downstream effects of concizumab in hemophilia A with a mathematical modeling approach
- 12 November 2024
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 23 (2) , 480-491
Open AccessExamining downstream effects of concizumab in hemophilia A with a mathematical modeling approach
- Open Access
- 12 September 2024
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 8 (7) , 102570
Mathematical modeling identifies clotting factor combinations that modify thrombin generation in normal and factor VIII-, IX-, or XI-deficient blood
- 12 September 2024
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 8 (7) , 102570
Open AccessMathematical modeling identifies clotting factor combinations that modify thrombin generation in normal and factor VIII-, IX-, or XI-deficient blood
- Open Access
- 6 June 2024
- Published by Elsevier in Mathematical Biosciences
- Vol. 374, 109229
Modeling the distribution of enzymes on lipid vesicles: A novel framework for surface-mediated reactions in coagulation
- 6 June 2024
- Published by Elsevier in Mathematical Biosciences
- Vol. 374, 109229
Open AccessModeling the distribution of enzymes on lipid vesicles: A novel framework for surface-mediated reactions in coagulation